Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-011033
Filing Date
2025-05-15
Accepted
2025-05-15 16:45:56
Documents
73
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1111456
2 EX-10.1 ex10-1.htm EX-10.1 41641
3 EX-31.1 ex31-1.htm EX-31.1 19135
4 EX-31.2 ex31-2.htm EX-31.2 18666
5 EX-32.1 ex32-1.htm EX-32.1 7493
6 EX-32.2 ex32-2.htm EX-32.2 7419
  Complete submission text file 0001641172-25-011033.txt   5966991

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE aimi-20250331.xsd EX-101.SCH 43396
8 XBRL CALCULATION FILE aimi-20250331_cal.xml EX-101.CAL 56784
9 XBRL DEFINITION FILE aimi-20250331_def.xml EX-101.DEF 206035
10 XBRL LABEL FILE aimi-20250331_lab.xml EX-101.LAB 356422
11 XBRL PRESENTATION FILE aimi-20250331_pre.xml EX-101.PRE 288872
75 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 879293
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 25954627
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)